How much profit has Imara made this year?
Imara has made -14.21 M USD this year.
Imara Net Income 2024
Imara Net Income
-14.21 M USD
Ticker
IMRA
ISIN
US45249V1070
WKN
A2P0EP
In 2024, Imara's profit amounted to -14.21 M USD, a -0.19% increase from the -14.24 M USD profit recorded in the previous year.
The Imara Net Income history
| YEAR | NET INCOME (undefined USD) |
|---|---|
| 2026e | -19.23 |
| 2025e | -13.49 |
| 2024e | -14.21 |
| 2023e | -14.24 |
| 2022 | 1.49 |
| 2021 | -51.38 |
| 2020 | -49.22 |
| 2019 | -23.46 |
| 2018 | -11.34 |
| 2017 | 0.22 |
Imara Revenue, EBIT, Net Income US45249V1070 · A2P0EP
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Imara, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Imara from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Imara’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Imara. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Imara’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Imara’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Imara’s growth potential.
Imara Revenue, EBIT and net profit per share
| Date | Imara Revenue | Imara EBIT | Imara Net Income |
|---|---|---|---|
| 2026e | 15.74 M undefined | -34.08 M undefined | -19.23 M undefined |
| 2025e | 14.99 M undefined | -24.95 M undefined | -13.49 M undefined |
| 2024e | 0 undefined | -14.34 M undefined | -14.21 M undefined |
| 2023e | 0 undefined | -14.34 M undefined | -14.24 M undefined |
| 2022 | 0 undefined | -34.27 M undefined | 1.49 M undefined |
| 2021 | 0 undefined | -51.44 M undefined | -51.38 M undefined |
| 2020 | 0 undefined | -41.7 M undefined | -49.22 M undefined |
| 2019 | 0 undefined | -24.12 M undefined | -23.46 M undefined |
| 2018 | 0 undefined | -10.68 M undefined | -11.34 M undefined |
| 2017 | 0 undefined | -8.91 M undefined | 221,000 undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2017 | 0 USD | -8.91 M USD | 221,000 USD |
| 2018 | 0 USD | -10.68 M USD | -11.34 M USD |
| 2019 | 0 USD | -24.12 M USD | -23.46 M USD |
| 2020 | 0 USD | -41.7 M USD | -49.22 M USD |
| 2021 | 0 USD | -51.44 M USD | -51.38 M USD |
| 2022 | 0 USD | -34.27 M USD | 1.49 M USD |
| 2023e | 0 USD | -14.34 M USD | -14.24 M USD |
| 2024e | 0 USD | -14.34 M USD | -14.21 M USD |
| 2025e | 14.99 M USD | -24.95 M USD | -13.49 M USD |
| 2026e | 15.74 M USD | -34.08 M USD | -19.23 M USD |
Imara stock margins US45249V1070 · A2P0EP
The Imara margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Imara. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Imara.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Imara's sales revenue. A higher gross margin percentage indicates that the Imara retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Imara's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Imara's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Imara's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Imara. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Imara's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Imara Margin History
| Imara Gross margin | Imara Profit margin | Imara EBIT margin | Imara Profit margin |
|---|---|---|---|
| 2026e | 0 % | -216.56 % | -122.18 % |
| 2025e | 0 % | -166.48 % | -90 % |
| 2024e | 0 % | 0 % | 0 % |
| 2023e | 0 % | 0 % | 0 % |
| 2022 | 0 % | 0 % | 0 % |
| 2021 | 0 % | 0 % | 0 % |
| 2020 | 0 % | 0 % | 0 % |
| 2019 | 0 % | 0 % | 0 % |
| 2018 | 0 % | 0 % | 0 % |
| 2017 | 0 % | 0 % | 0 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2017 | 0 % | 0 % | 0 % |
| 2018 | 0 % | 0 % | 0 % |
| 2019 | 0 % | 0 % | 0 % |
| 2020 | 0 % | 0 % | 0 % |
| 2021 | 0 % | 0 % | 0 % |
| 2022 | 0 % | 0 % | 0 % |
| 2023e | 0 % | 0 % | 0 % |
| 2024e | 0 % | 0 % | 0 % |
| 2025e | 0 % | -166.48 % | -90 % |
| 2026e | 0 % | -216.56 % | -122.18 % |
Imara Aktienanalyse
What does Imara do?
Imara Inc is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for rare blood diseases. The company was founded in 2016 by experienced industry veterans who shared a vision of developing new and more effective treatments for patients with rare blood diseases. Imara is headquartered in Boston, Massachusetts, and has a subsidiary in Lausanne, Switzerland. Imara's business model is based on identifying unmet medical needs in the treatment of rare blood diseases and developing drugs that can address these needs. The company has focused on closing treatment gaps by developing new therapeutics that target the suppression of inflammatory isoforms of an enzyme called PDE9. These isoforms are often elevated in patients with rare blood diseases and contribute to disease worsening. Imara has several therapeutics in various stages of clinical development. The lead product, IMR-687, is an oral medication for the treatment of sickle cell anemia and β-thalassemia. IMR-687 has the potential to significantly reduce the frequency and severity of pain episodes in sickle cell patients while also lowering the risk of lung infections. Other potential areas of application for the medication include pulmonary hypertension, kidney diseases, and other blood disorders. Imara also has a pipeline of other compounds, including IMR-816 (another PDE9 inhibitor), which is currently in phase 1 studies for the treatment of amyloidosis. Amyloidosis is a rare protein deposition disorder that can affect various organs such as the heart, kidneys, liver, or nervous system. Furthermore, Imara is working on developing IMR-687 as a therapy for inherited blistering disorders. This rare condition, also known as "epidermolysis bullosa," is a genetically based skin disorder characterized by chronic wounds and scarring. It significantly impairs the quality of life for those affected. Imara collaborates closely with patient organizations, academic institutions, and regulatory authorities to ensure that its products can be made accessible quickly and safely. The company pursues a comprehensive clinical development strategy to reduce the impact of rare blood diseases on patients. Overall, Imara is a dynamic company focused on meeting medical needs and providing an excellent working environment for dedicated and goal-oriented employees. Imara hopes to continue its commitment to innovation and excellence as it continues to grow and focuses on improving the lives of people with rare blood diseases. Imara ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Imara's Profit Margins
The profit margins of Imara represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Imara's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Imara's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Imara's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Imara’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Imara stock
How has the profit developed compared to last year?
The profit has increased by -0.19% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Imara publish its earnings?
Imara publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Imara?
The profits of Imara are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Imara?
You can learn more about the earnings of Imara by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Imara pay?
Over the past 12 months, Imara paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Imara is expected to pay a dividend of 0 USD.
What is the dividend yield of Imara?
The current dividend yield of Imara is .
When does Imara pay dividends?
Imara pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Imara?
Imara paid dividends every year for the past 0 years.
What is the dividend of Imara?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Imara located?
Imara is assigned to the 'Health' sector.
Wann musste ich die Aktien von Imara kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Imara from 11/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.
When did Imara pay the last dividend?
The last dividend was paid out on 11/8/2024.
What was the dividend of Imara in the year 2023?
In the year 2023, Imara distributed 0 USD as dividends.
In which currency does Imara pay out the dividend?
The dividends of Imara are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Imara
Our stock analysis for Imara Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Imara Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
